Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease

Kiyohiko Izumi, Kozo Morimoto, Kazuhiro Uchimura, Manabu Ato, Naoki Hasegawa, Satoshi Mitarai
ERJ Open Research 2020 6: 00097-2019; DOI: 10.1183/23120541.00097-2019
Kiyohiko Izumi
1The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
6These authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kizumi95@gmail.com
Kozo Morimoto
1The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
2Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan
6These authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuhiro Uchimura
1The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manabu Ato
3Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manabu Ato
Naoki Hasegawa
4Keio University School of Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoshi Mitarai
1The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
5Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 6 no. 1
DOI 
https://doi.org/10.1183/23120541.00097-2019

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received April 15, 2019
  • Accepted January 12, 2020
  • Published online March 23, 2020.

Copyright & Usage 
Copyright ©ERS 2020 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Kiyohiko Izumi1,6⇑,
  2. Kozo Morimoto1,2,6,
  3. Kazuhiro Uchimura1,
  4. Manabu Ato3,
  5. Naoki Hasegawa4 and
  6. Satoshi Mitarai1,5
  1. 1The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
  2. 2Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan
  3. 3Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan
  4. 4Keio University School of Medicine, Tokyo, Japan
  5. 5Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
  6. 6These authors contributed equally
  1. Kiyohiko Izumi, Dept of Epidemiology and Clinical Research, The Research Institute of Tuberculosis, Anti-Tuberculosis Association, 3-1-24, Matsuyama, Kiyose, Tokyo 204-8533, Japan. E-mail: kizumi95{at}gmail.com
View Full Text

Funding

  • Japan Agency for Medical Research and Development

    JP18fk0108043

Article usage

Article usage: March 2020 to January 2023

AbstractFullPdf
Mar 2020010336
Apr 2020311941
May 202023824
Jun 202021815
Jul 20201296
Aug 202002915
Sep 20200391
Oct 202013517
Nov 20201169
Dec 202011511
Jan 20212143
Feb 2021090
Mar 20210174
Apr 2021064
May 20211228
Jun 20210246
Jul 202112710
Aug 20211165
Sep 20212336
Oct 202112023
Nov 202103221
Dec 202101711
Jan 2022060
Feb 20220125
Mar 20221107
Apr 2022082
May 202201317
Jun 202201513
Jul 202201052
Aug 202201714
Sep 202201217
Oct 202201719
Nov 202211914
Dec 20220724
Jan 202302412

Altmetrics

PreviousNext
Back to top
Vol 6 Issue 1 Table of Contents
ERJ Open Research: 6 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
Kiyohiko Izumi, Kozo Morimoto, Kazuhiro Uchimura, Manabu Ato, Naoki Hasegawa, Satoshi Mitarai
ERJ Open Research Jan 2020, 6 (1) 00097-2019; DOI: 10.1183/23120541.00097-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
Kiyohiko Izumi, Kozo Morimoto, Kazuhiro Uchimura, Manabu Ato, Naoki Hasegawa, Satoshi Mitarai
ERJ Open Research Jan 2020, 6 (1) 00097-2019; DOI: 10.1183/23120541.00097-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • rs2070600 SNP regulates AGER splicing and sputum sRAGE
  • Expression profiling by RNA-Seq in bronchial biopsies of COPD patients
  • Procoagulant microparticles and COVID-19
Show more Original research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society